Evidence map›Paper›PMID 37145842›Full record

ArticleJMIR research protocols2023

Impact of California's Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data.

Ana Florea, Joan A Casey, Keeve Nachman, Lance B Price, Magdalena E Pomichowski, Harpreet S Takhar, Vanessa Quinlivan, Lee D Childs, Meghan F Davis, Rong Wei and 8 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. ZoonoticmBio · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Ana FloreaDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0000-0003-0030-8737
Joan A CaseyColumbia University Mailman School of Public Health, New York City, NY, United States.ORCID https://orcid.org/0000-0002-9809-4695
Keeve NachmanJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0003-4925-4151
Lance B PriceMilken Institute School of Public Health, George Washington University, Washington, DC, United States.ORCID https://orcid.org/0000-0002-8746-5307
Magdalena E PomichowskiDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0009-0004-7280-9084
Harpreet S TakharDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0000-0002-2734-4896
Vanessa QuinlivanMilken Institute School of Public Health, George Washington University, Washington, DC, United States.ORCID https://orcid.org/0000-0002-8546-6592
Lee D ChildsDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0009-0000-5451-2704
Meghan F DavisJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0002-3475-4578
Rong WeiDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0000-0003-0204-4982
Vennis HongDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0000-0002-6060-8419
Jennifer H KuDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0000-0001-9469-5875
Cindy M LiuMilken Institute School of Public Health, George Washington University, Washington, DC, United States.ORCID https://orcid.org/0000-0003-4537-173X
Alice PressmanCenter for Health Systems Research, Sutter Health, Walnut Creek, CA, United States.ORCID https://orcid.org/0000-0003-2775-3275
Sarah RobinsonCenter for Health Systems Research, Sutter Health, Walnut Creek, CA, United States.ORCID https://orcid.org/0000-0002-6553-8085
Katia J BruxvoortDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States.ORCID https://orcid.org/0000-0001-8277-2431
S Bianca SalasDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0009-0005-3183-7369
Sara Y TartofDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID https://orcid.org/0000-0003-2336-8476
Kaiser Permanente · USMilken Institute · USJohns Hopkins University · USSutter Health · USColumbia University · USUniversity of Alabama at Birmingham · US

Funding

Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experimentR01AI130066 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI TARTOF, SARA · 2017 to 2021
$3.8M
NIAID NIH HHS R01 AI130066Wellcome Trust
6 · The paper itself

Abstract

backgroundOveruse of antibiotics contributes to antimicrobial resistance (AMR) and is a growing threat to human health worldwide. Previous work suggests a link between antimicrobial use in poultry and human AMR extraintestinal pathogenic Escherichia coli (E coli) urinary tract infections (UTIs). However, few US-based studies exist, and none have comprehensively assessed both foodborne and environmental pathways using advanced molecular and spatial epidemiologic methods in a quasi-experimental design. Recently, California enacted Senate Bill 27 (SB27), which changed previous policy to require a veterinarian's prescription for the use of antibiotic drugs, and which banned antibiotic use for disease prevention in livestock. This provided an opportunity to evaluate whether SB27 will result in a reduction in antimicrobial-resistant infections in humans.

objectiveWe describe in detail the methods implemented to achieve the overarching objective of this study to evaluate the impact of SB27 on downstream antibiotic resistance rates in human UTIs.

methodsA summary of the overall approach and the partnerships between Columbia University, George Washington University (GWU), Johns Hopkins Bloomberg School of Public Health, Kaiser Permanente Southern California (KPSC) Research and Evaluation, the Natural Resources Defense Council, Sanger Institute at Stanford University, Sutter Health Center for Health Systems Research, the University of Cambridge, and the University of Oxford is presented. The collection, quality control testing, and shipment of retail meat and clinical samples are described. Retail meat (chicken, beef, turkey, and pork) was purchased from stores throughout Southern California from 2017 to 2021. After processing at KPSC, it was shipped to GWU for testing. From 2016 to 2021, after clinical specimens were processed for routine clinical purposes and immediately before discarding, those with isolated colonies of E coli, Campylobacter, and Salmonella from KPSC members were collected and processed to be shipped for testing at GWU. Detailed methods of the isolation and testing as well as the whole-genome sequencing of the meat and clinical samples at GWU are described. KPSC electronic health record data were used to track UTI cases and AMR patterns among the cultured specimens. Similarly, Sutter Health electronic health record data were used to track UTI cases in its Northern California patient population.

resultsFrom 2017 to 2021, overall, 12,616 retail meat samples were purchased from 472 unique stores across Southern California. In addition, 31,643 positive clinical cultures were collected from KPSC members during the same study period.

conclusionsHere, we presented data collection methods for the study, which was conducted to evaluate the impact of SB27 on downstream antibiotic resistance rates in human UTI. To date, it is one of the largest studies of its kind to be conducted. The data collected during this study will be used as the foundation for future analyses specific to the various objectives of this large body of work. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/45109.

Indexed as

AMRantimicrobial resistanceE coliEscherichia coliurinary tract infectionUTI

Identifiers

PMID37145842
PMCPMC10199382
OpenAlexW4372337350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.